Pioneering the Future of Fertility Preservation at KIMS Fertility, Secunderabad & Mother To Be Fertility Centre, Hyderabad – April 27, 2025
As someone deeply committed to advancing the frontiers of reproductive medicine, I am proud to share that we have successfully initiated both Ovarian Tissue Cryopreservation (OTC) at our facility — a first-of-its-kind offering in Hyderabad at KIMS Fertility Centre and Mother To Be Fertility Centre. With decades of experience and being very passionate about offering fertility preservation, , this marks a major milestone, especially for young women at risk of losing their reproductive potential.
These advanced fertility preservation services are now fully accessible at our centers, providing crucial options for oncology patients undergoing gonadotoxic treatments such as chemotherapy and radiotherapy, as well as those with benign conditions including severe rheumatological diseases, hematological disorders, and extensive endometriosis — all of which may compromise ovarian function.
OTC opens up new possibilities by offering the potential to restore natural fertility and hormonal function, giving women a second chance at parenthood even after fertility-compromising treatments.
It has been a true privilege to engage with one of the global pioneers of ovarian tissue cryopreservation, whose groundbreaking work has laid the foundation for initiatives like ours to flourish and directly impact patient care.
At Mother To Be Fertility Centre and KIMS Fertility Centre, our mission is clear — to lead with innovation, compassion, and clinical excellence, ensuring that the dream of future parenthood remains a reality for every woman who walks through our doors.
